Compare Stocks

3 / 10
Try these comparisons:

Stock Comparison

NEU vs ALB vs IOSP

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NEU
NewMarket Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$6.38B
5Y Perf.+55.7%
ALB
Albemarle Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$23.37B
5Y Perf.+159.2%
IOSP
Innospec Inc.

Chemicals - Specialty

Basic MaterialsNASDAQ • US
Market Cap$1.91B
5Y Perf.-0.6%

NEU vs ALB vs IOSP — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NEU logoNEU
ALB logoALB
IOSP logoIOSP
IndustryChemicals - SpecialtyChemicals - SpecialtyChemicals - Specialty
Market Cap$6.38B$23.37B$1.91B
Revenue (TTM)$2.69B$5.49B$1.78B
Net Income (TTM)$411M$-233M$117M
Gross Margin31.3%18.5%27.7%
Operating Margin19.6%5.6%8.7%
Forward P/E15.3x22.4x15.5x
Total Debt$962M$3.30B$90M
Cash & Equiv.$78M$1.62B$293M

NEU vs ALB vs IOSPLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NEU
ALB
IOSP
StockMay 20May 26Return
NewMarket Corporati… (NEU)100155.7+55.7%
Albemarle Corporati… (ALB)100259.2+159.2%
Innospec Inc. (IOSP)10099.4-0.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: NEU vs ALB vs IOSP

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NEU leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Albemarle Corporation is the stronger pick specifically for recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
NEU
NewMarket Corporation
The Growth Play

NEU carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth -2.2%, EPS growth -7.8%, 3Y rev CAGR -0.5%
  • -2.2% revenue growth vs ALB's -4.4%
  • Lower P/E (15.3x vs 22.4x)
Best for: growth exposure
ALB
Albemarle Corporation
The Long-Run Compounder

ALB is the clearest fit if your priority is long-term compounding.

  • 217.0% 10Y total return vs NEU's 88.5%
  • +256.7% vs IOSP's -14.9%
Best for: long-term compounding
IOSP
Innospec Inc.
The Income Pick

IOSP is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 12 yrs, beta 0.70, yield 2.2%
  • Lower volatility, beta 0.70, Low D/E 6.7%, current ratio 2.79x
  • PEG 0.48 vs NEU's 1.22
Best for: income & stability and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthNEU logoNEU-2.2% revenue growth vs ALB's -4.4%
ValueNEU logoNEULower P/E (15.3x vs 22.4x)
Quality / MarginsNEU logoNEU15.3% margin vs ALB's -4.2%
Stability / SafetyNEU logoNEUBeta 0.56 vs ALB's 1.60
DividendsIOSP logoIOSP2.2% yield, 12-year raise streak, vs ALB's 0.8%
Momentum (1Y)ALB logoALB+256.7% vs IOSP's -14.9%
Efficiency (ROA)NEU logoNEU12.2% ROA vs ALB's -1.4%, ROIC 16.0% vs 0.6%

NEU vs ALB vs IOSP — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NEUNewMarket Corporation
FY 2025
Petroleum Additives
93.0%$2.5B
Specialty Materials
6.7%$182M
Other Operating Segment
0.3%$9M
ALBAlbemarle Corporation
FY 2025
Energy Storage
52.7%$2.7B
Specialties
26.6%$1.4B
Ketjen
20.7%$1.1B
IOSPInnospec Inc.
FY 2025
Fuel Specialties
39.5%$702M
Performance Chemicals
38.3%$681M
Oilfield Services
22.2%$395M

NEU vs ALB vs IOSP — Financial Metrics

Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLNEULAGGINGALB

Income & Cash Flow (Last 12 Months)

NEU leads this category, winning 4 of 6 comparable metrics.

ALB is the larger business by revenue, generating $5.5B annually — 3.1x IOSP's $1.8B. NEU is the more profitable business, keeping 15.3% of every revenue dollar as net income compared to ALB's -4.2%. On growth, ALB holds the edge at +32.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricNEU logoNEUNewMarket Corpora…ALB logoALBAlbemarle Corpora…IOSP logoIOSPInnospec Inc.
RevenueTrailing 12 months$2.7B$5.5B$1.8B
EBITDAEarnings before interest/tax$652M$802M$198M
Net IncomeAfter-tax profit$411M-$233M$117M
Free Cash FlowCash after capex$484M$577M$88M
Gross MarginGross profit ÷ Revenue+31.3%+18.5%+27.7%
Operating MarginEBIT ÷ Revenue+19.6%+5.6%+8.7%
Net MarginNet income ÷ Revenue+15.3%-4.2%+6.6%
FCF MarginFCF ÷ Revenue+18.0%+10.5%+4.9%
Rev. Growth (YoY)Latest quarter vs prior year-4.5%+32.7%-2.4%
EPS Growth (YoY)Latest quarter vs prior year-5.3%+167.7%
NEU leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

IOSP leads this category, winning 5 of 7 comparable metrics.

At 15.3x trailing earnings, NEU trades at a 7% valuation discount to IOSP's 16.4x P/E. Adjusting for growth (PEG ratio), IOSP offers better value at 0.51x vs NEU's 1.22x — a lower PEG means you pay less per unit of expected earnings growth.

MetricNEU logoNEUNewMarket Corpora…ALB logoALBAlbemarle Corpora…IOSP logoIOSPInnospec Inc.
Market CapShares × price$6.4B$23.4B$1.9B
Enterprise ValueMkt cap + debt − cash$7.3B$25.1B$1.7B
Trailing P/EPrice ÷ TTM EPS15.28x-34.50x16.41x
Forward P/EPrice ÷ next-FY EPS est.22.36x15.45x
PEG RatioP/E ÷ EPS growth rate1.22x0.51x
EV / EBITDAEnterprise value multiple10.91x33.21x8.29x
Price / SalesMarket cap ÷ Revenue2.34x4.55x1.07x
Price / BookPrice ÷ Book value/share3.58x2.39x1.44x
Price / FCFMarket cap ÷ FCF12.99x33.76x21.68x
IOSP leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

NEU leads this category, winning 5 of 9 comparable metrics.

NEU delivers a 39.3% return on equity — every $100 of shareholder capital generates $39 in annual profit, vs $-2 for ALB. IOSP carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to NEU's 0.54x. On the Piotroski fundamental quality scale (0–9), ALB scores 6/9 vs NEU's 5/9, reflecting solid financial health.

MetricNEU logoNEUNewMarket Corpora…ALB logoALBAlbemarle Corpora…IOSP logoIOSPInnospec Inc.
ROE (TTM)Return on equity+39.3%-2.3%+9.0%
ROA (TTM)Return on assets+12.2%-1.4%+6.5%
ROICReturn on invested capital+16.0%+0.6%+11.2%
ROCEReturn on capital employed+18.7%+0.6%+11.0%
Piotroski ScoreFundamental quality 0–9566
Debt / EquityFinancial leverage0.54x0.34x0.07x
Net DebtTotal debt minus cash$884M$1.7B-$203M
Cash & Equiv.Liquid assets$78M$1.6B$293M
Total DebtShort + long-term debt$962M$3.3B$90M
Interest CoverageEBIT ÷ Interest expense14.71x1.59x
NEU leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — NEU and ALB each lead in 3 of 6 comparable metrics.

A $10,000 investment in NEU five years ago would be worth $20,613 today (with dividends reinvested), compared to $8,168 for IOSP. Over the past 12 months, ALB leads with a +256.7% total return vs IOSP's -14.9%. The 3-year compound annual growth rate (CAGR) favors NEU at 21.8% vs IOSP's -6.1% — a key indicator of consistent wealth creation.

MetricNEU logoNEUNewMarket Corpora…ALB logoALBAlbemarle Corpora…IOSP logoIOSPInnospec Inc.
YTD ReturnYear-to-date-0.8%+38.1%+0.5%
1-Year ReturnPast 12 months+9.9%+256.7%-14.9%
3-Year ReturnCumulative with dividends+80.8%+9.3%-17.3%
5-Year ReturnCumulative with dividends+106.1%+26.8%-18.3%
10-Year ReturnCumulative with dividends+88.5%+217.0%+84.4%
CAGR (3Y)Annualised 3-year return+21.8%+3.0%-6.1%
Evenly matched — NEU and ALB each lead in 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — NEU and ALB each lead in 1 of 2 comparable metrics.

NEU is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than ALB's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALB currently trades 89.8% from its 52-week high vs NEU's 77.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNEU logoNEUNewMarket Corpora…ALB logoALBAlbemarle Corpora…IOSP logoIOSPInnospec Inc.
Beta (5Y)Sensitivity to S&P 5000.56x1.60x0.70x
52-Week HighHighest price in past year$875.97$221.00$95.55
52-Week LowLowest price in past year$580.03$53.70$65.58
% of 52W HighCurrent price vs 52-week peak+77.5%+89.8%+80.2%
RSI (14)Momentum oscillator 0–10061.853.059.1
Avg Volume (50D)Average daily shares traded129K2.0M221K
Evenly matched — NEU and ALB each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — ALB and IOSP each lead in 1 of 2 comparable metrics.

Analyst consensus: NEU as "Hold", ALB as "Hold", IOSP as "Hold". Consensus price targets imply 50.1% upside for IOSP (target: $115) vs -3.8% for ALB (target: $191). For income investors, IOSP offers the higher dividend yield at 2.21% vs ALB's 0.82%.

MetricNEU logoNEUNewMarket Corpora…ALB logoALBAlbemarle Corpora…IOSP logoIOSPInnospec Inc.
Analyst RatingConsensus buy/hold/sellHoldHoldHold
Price TargetConsensus 12-month target$190.80$115.00
# AnalystsCovering analysts4459
Dividend YieldAnnual dividend ÷ price+1.7%+0.8%+2.2%
Dividend StreakConsecutive years of raises71512
Dividend / ShareAnnual DPS$11.29$1.62$1.70
Buyback YieldShare repurchases ÷ mkt cap+1.2%0.0%0.0%
Evenly matched — ALB and IOSP each lead in 1 of 2 comparable metrics.
Key Takeaway

NEU leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). IOSP leads in 1 (Valuation Metrics). 3 tied.

Best OverallNewMarket Corporation (NEU)Leads 2 of 6 categories
Loading custom metrics...

NEU vs ALB vs IOSP: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is NEU or ALB or IOSP a better buy right now?

For growth investors, NewMarket Corporation (NEU) is the stronger pick with -2.

2% revenue growth year-over-year, versus -4. 4% for Albemarle Corporation (ALB). NewMarket Corporation (NEU) offers the better valuation at 15. 3x trailing P/E, making it the more compelling value choice. Analysts rate NewMarket Corporation (NEU) a "Hold" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — NEU or ALB or IOSP?

On trailing P/E, NewMarket Corporation (NEU) is the cheapest at 15.

3x versus Innospec Inc. at 16. 4x. On forward P/E, Innospec Inc. is actually cheaper at 15. 5x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — NEU or ALB or IOSP?

Over the past 5 years, NewMarket Corporation (NEU) delivered a total return of +106.

1%, compared to -18. 3% for Innospec Inc. (IOSP). Over 10 years, the gap is even starker: ALB returned +217. 0% versus IOSP's +84. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — NEU or ALB or IOSP?

By beta (market sensitivity over 5 years), NewMarket Corporation (NEU) is the lower-risk stock at 0.

56β versus Albemarle Corporation's 1. 60β — meaning ALB is approximately 184% more volatile than NEU relative to the S&P 500. On balance sheet safety, Innospec Inc. (IOSP) carries a lower debt/equity ratio of 7% versus 54% for NewMarket Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — NEU or ALB or IOSP?

By revenue growth (latest reported year), NewMarket Corporation (NEU) is pulling ahead at -2.

2% versus -4. 4% for Albemarle Corporation (ALB). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to -7. 8% for NewMarket Corporation. Over a 3-year CAGR, NEU leads at -0. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — NEU or ALB or IOSP?

NewMarket Corporation (NEU) is the more profitable company, earning 15.

4% net margin versus -9. 9% for Albemarle Corporation — meaning it keeps 15. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NEU leads at 20. 0% versus 1. 8% for ALB. At the gross margin level — before operating expenses — NEU leads at 31. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is NEU or ALB or IOSP more undervalued right now?

On forward earnings alone, Innospec Inc.

(IOSP) trades at 15. 5x forward P/E versus 22. 4x for Albemarle Corporation — 6. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IOSP: 50. 1% to $115. 00.

08

Which pays a better dividend — NEU or ALB or IOSP?

All stocks in this comparison pay dividends.

Innospec Inc. (IOSP) offers the highest yield at 2. 2%, versus 0. 8% for Albemarle Corporation (ALB).

09

Is NEU or ALB or IOSP better for a retirement portfolio?

For long-horizon retirement investors, NewMarket Corporation (NEU) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

56), 1. 7% yield). Albemarle Corporation (ALB) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NEU: +88. 5%, ALB: +217. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between NEU and ALB and IOSP?

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: NEU is a small-cap deep-value stock; ALB is a mid-cap quality compounder stock; IOSP is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

NEU

Income & Dividend Stock

  • Sector: Basic Materials
  • Market Cap > $100B
  • Net Margin > 9%
  • Dividend Yield > 0.6%
Run This Screen
Stocks Like

ALB

High-Growth Disruptor

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 16%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

IOSP

Income & Dividend Stock

  • Sector: Basic Materials
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 0.8%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform NEU and ALB and IOSP on the metrics below

Revenue Growth>
%
(NEU: -4.5% · ALB: 32.7%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.